drugset / Trial / NCT00489606
Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530
RandomizedCrossoverDouble-blindTreatment
Summary
To assess the pharamcodynamic effects of coadministrated SK3530(PDE5 inhibitor) and tamsulosin, phase I study in healthy volunteers was designed.
Timeline
- Start
- 2007-04
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirodenafil | Small molecule | 100 mg | Oral |